Matveeva
Evgenia Matveeva, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20140273038 | BIOLUMINESCENT METAL ION ASSAY - A method for determining metal ions, both qualitatively and quantitatively, is disclosed. The method utilizes emission from fluorescence resonance energy transfer from a luciferase-carbonic anhydrase conjugate or fusion protein to an acceptor ligand in the presence of metal ion bound to the protein to measure free metal ion concentrations down to picomolar concentration ranges. The method is relatively insensitive to contaminants, and so can be used to measure metal ion concentrations in cells, body fluids or environmental samples without extensive sample preparation. | 09-18-2014 |
Evgenia Matveeva, Fort Worth, TX US
Patent application number | Description | Published |
---|---|---|
20090218516 | Ratiometric Surface Plasmon Coupled Emission Detector - The present invention includes methods for ratiometric detection of analytes by surface plasmon coupled emission detection that includes disposing a target on the metal layer of a surface plasmon resonance detection system; coupling a first analyte to a first fluorescent dye and a second analyte to a second fluorescent dye; contacting the first and second analytes to the target on the surface plasmon resonance detection system; and measuring the intensity of a first and a second surface plasmon resonance enhanced fluorescence emission ring, wherein the first and second rings, respectively, quantitatively represents the amount of first and second analyte within 50 nanometers of the metal surface. | 09-03-2009 |
Irina Matveeva, Moscow RU
Patent application number | Description | Published |
---|---|---|
20130209607 | Enzymatic Flour Correction - The present invention is directed to methods for improving flour quality (e.g., a flour correction process) by treating flour with a raw starch degrading enzyme. | 08-15-2013 |
Irina Alexandrovna Matveeva, Moskau RU
Patent application number | Description | Published |
---|---|---|
20080217590 | PHOTOCHROMIC MATERIAL AND PROCESS FOR ITS PREPARATION - A curable composition which has photochromic properties and is based on an acrylic compound which can undergo free-radical polymerization, a cured product which is obtained by thermal or photochemical curing of this curable composition on a substrate, e.g. polycarbonate glass with triplex formation (three-layered structure), and a process for the preparation of an optical material are described. | 09-11-2008 |
Olga Matveeva, Salt Lake City, UT US
Patent application number | Description | Published |
---|---|---|
20100113292 | METHODS OF OBTAINING ACTIVE ANTISENSE COMPOUNDS - Methods for obtaining antisense oligonucleotides with activity against a desired target are provided. Methods of identifying oligonucleotide sequence motifs which are predictive of antisense oligonucleotide activity are provided, as are motifs identified according to this method. Methods of selecting effective antisense oligonucleotide sequences and effective antisense target sequences are provided, as are sequences selected according to these methods. In other methods of the invention, oligonucleotides are designed to hybridize to target sequences containing one or more activity-enhancing motifs. Antisense oligonucleotides designed according to these methods are also provided. | 05-06-2010 |
Olga Matveeva, Acton, MA US
Patent application number | Description | Published |
---|---|---|
20160022808 | Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic Sendai virus - The invention relates to the field of immunology and medicine, more specifically, oncology, and can be useful for the treatment of patients with carcinomas and sarcomas. A pharmaceutical composition is provided which contains biologically active oncolytic Sendai virus strain Moscow PTA-13024, and a method of treating patients with said malignancies is developed including administration of the said composition to a patient's body. The strain Sendai-Moscow PTA-13024 is characterized by high oncolytic activity and safety for humans. The exploitation of the invention allows an increase in efficacy of treatment due to direct elimination of malignant cells via virus action and induction of anti-tumor immunity by viruses. | 01-28-2016 |
Olga Vyacheslavovna Matveeva, Moscow RU
Patent application number | Description | Published |
---|---|---|
20160022808 | Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic Sendai virus - The invention relates to the field of immunology and medicine, more specifically, oncology, and can be useful for the treatment of patients with carcinomas and sarcomas. A pharmaceutical composition is provided which contains biologically active oncolytic Sendai virus strain Moscow PTA-13024, and a method of treating patients with said malignancies is developed including administration of the said composition to a patient's body. The strain Sendai-Moscow PTA-13024 is characterized by high oncolytic activity and safety for humans. The exploitation of the invention allows an increase in efficacy of treatment due to direct elimination of malignant cells via virus action and induction of anti-tumor immunity by viruses. | 01-28-2016 |